Rebecca M. McDougle

发表

APOBEC3B is an enzymatic source of mutation in breast cancer

N. A. Temiz, Jason B. Nikas, R. Harris, 2013, Nature.

HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

R. Harris, Rebecca M. McDougle, J. Hultquist, 2012, AIDS research and human retroviruses.

APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

R. Harris, M. Carpenter, Rebecca M. McDougle, 2014, Journal of molecular biology.

Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B

J. Martens, P. Span, M. Carpenter, 2020, eLife.

D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

Rebecca M. McDougle, J. Hultquist, S. Sawyer, 2013, Virology.

D 316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC 3 B

Rebecca M. McDougle, J. Hultquist, S. Sawyer, 2013 .

The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.

Rebecca M. McDougle, W. Brown, P. Parker, 2015, Cancer research.

APOBEC3B is an enzymatic source of mutation in breast cancer

Jason B. Nikas, Lela Lackey, M. Carpenter, 2013, Nature.

Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

C. Schiffer, M. Carpenter, A. Rathore, 2013, Structure.

The PKC / NFk B Signaling Pathway Induces APOBEC 3 BExpression inMultiple HumanCancers

Rebecca M. McDougle, W. Brown, P. Parker, 2015 .

The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.

Rebecca M. McDougle, W. Brown, P. Parker, 2015, Cancer research.